Processing

Please wait...

Settings

Settings

1. WO2007003447 - COATED GRANULAR FORMULATIONS

Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters

CLAIMS
1. Granular formulation based on granules formed by an inner core essentially consisting of at least one active component, or a salt thereof pharmaceutically established in pharmaceutical practice in an amount of between 50% and 90% by weight of the formulation, and by an outer coating essentially consisting of hydrogenated vegetable fats in an amount of between 10% and 50% by weight of the formulation.
2. Granular formulation according to Claim 1, in which said active component is present in an amount of between 60% and 80% by weight.
3. Granular formulation according to any of the preceding claims, in which the hydrogenated vegetable fats are present in an amount of between 20% and 40% by weight .
4. Granular formulation according to any of the preceding claims, in which said active component is non-palatable, hygroscopic, oxidisable and/or photosensitive .
5. Granular formulation according to any of the preceding claims, in which the active component is chosen from among: SAMe, SOD, reduced glutathione, lactic ferments, dimetrazine, proteolytic enzymes, NADH, creatine, magnesium chloride, amino acids.
6. Granular formulation according to any of the preceding claims, in which the hydrogenated vegetable fats are chosen from among: mono-, di-, triglyceryl behenates, glyceryl palmitostearate, polyethylene glycol esters of fatty acids and/or waxes .
7. Granular formulation according to any of the preceding claims, in which the hydrogenated vegetable fats have a melting point of between 30° and 1000C.

8. Granular formulation according to any of the preceding claims, in which the hydrogenated vegetable fats have a melting point of between 50° and 8O0C.
9. Granular formulation according to any one of the preceding claims, in which the hydrogenated vegetable fats are hydrogenated fatty acids or mixtures thereof having chains of 14 to 22 carbon atoms.
10. Granular formulation according to any of the preceding claims, in which the granules have a particle size of between 250 and 3000 μ.
11. Granular formulation according to any of the preceding claims, in which the granules have a particle size of between 250 and 1000 μ.
12. Granular formulation according to any of the preceding claims, characterized in that it contains pharmaceutically acceptable excipients and/or adjuvants in an amount of between 2% and 10%, relative to the weight of the formulation.
13. Formulation according to Claim 12, in which said excipients and/or adjuvants are present in an amount of between 3% and 5%, relative to the weight of the formulation .
14. Formulation according to any of the preceding claims, in which the active component is a salt of SAMe chosen from among: disulphate ditosylate, disulphate para-toluenesulphonate, 1, 4-butanedisulphonate and/or hexamethanephosphonate .
15. Mixture for veterinary use containing feed and a formulation according to any of the preceding claims .